Cherry Creek Investment Advisors, Inc. Aclaris Therapeutics, Inc. Transaction History

Cherry Creek Investment Advisors, Inc.

  • $188 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022
SELL
$9.74 - $17.92 $111,425 - $205,004
-11,440 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$12.27 - $18.49 $13,190 - $19,876
-1,075 Reduced 8.59%
11,440 $166,000
Q3 2021

Nov 01, 2021
BUY
$13.38 - $18.8 $167,450 - $235,282
12,515 New
12,515 $225,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Cherry Creek Investment Advisors, Inc. Portfolio

Follow Cherry Creek Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cherry Creek Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cherry Creek Investment Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email